
Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research. The fact that patients’ mental deterioration slows when they’re on anti-amyloid drugs is solid proof that abnormal amyloid proteins are one of the culprits behind Alzheimer’s, essentially ending decades of debate over the so-called “amyloid… read on > read on >